BACKGROUND: Vitamin C has shown several beneficial effects on sepsis in preclinical studies. However, clinical data supporting these reports are scarce. This study aimed to evaluate whether adjunctive intravenous vitamin C therapy could reduce hospital mortality in patients with severe sepsis or septic shock requiring mechanical ventilation. METHODS: For this retrospective cohort study, consecutive medical ICU patients with severe sepsis or septic shock requiring mechanical ventilation were included. The study patients were classified into the vitamin C or control groups depending on the administration of intravenous vitamin C (2 g every 8 hours). The primary outcome was hospital mortality. RESULTS: Thirty-five patients in the vitamin C group and 40 patients in the control group were included. The two groups were comparable in regards to the baseline characteristics at ICU admission. The hospital mortality was 46% (16 of 35 patients) in the vitamin C group and 40% (16 of 40 patients) in the control group, showing a statistically nonsignificant difference (P=0.62). The mortality at 90 days after ICU admission (60% vs. 48%) did not significantly differ between groups. The median time to shock reversal was 3 days [interquartile range (IQR), 2 to 5 days] in both groups. The changes in the Sepsis-related Organ Failure Assessment (SOFA) scores during the first 4 ICU days were -1.4±3.3 and -1.4±3.0 in the vitamin C and control groups, respectively. CONCLUSIONS: Adjunctive intravenous vitamin C therapy alone did not reduce hospital mortality in mechanically ventilated patients with severe sepsis or septic shock.
BACKGROUND: Vitamin C has shown several beneficial effects on sepsis in preclinical studies. However, clinical data supporting these reports are scarce. This study aimed to evaluate whether adjunctive intravenous vitamin C therapy could reduce hospital mortality in patients with severe sepsis or septic shock requiring mechanical ventilation. METHODS: For this retrospective cohort study, consecutive medical ICU patients with severe sepsis or septic shock requiring mechanical ventilation were included. The study patients were classified into the vitamin C or control groups depending on the administration of intravenous vitamin C (2 g every 8 hours). The primary outcome was hospital mortality. RESULTS: Thirty-five patients in the vitamin C group and 40 patients in the control group were included. The two groups were comparable in regards to the baseline characteristics at ICU admission. The hospital mortality was 46% (16 of 35 patients) in the vitamin C group and 40% (16 of 40 patients) in the control group, showing a statistically nonsignificant difference (P=0.62). The mortality at 90 days after ICU admission (60% vs. 48%) did not significantly differ between groups. The median time to shock reversal was 3 days [interquartile range (IQR), 2 to 5 days] in both groups. The changes in the Sepsis-related Organ Failure Assessment (SOFA) scores during the first 4 ICU days were -1.4±3.3 and -1.4±3.0 in the vitamin C and control groups, respectively. CONCLUSIONS: Adjunctive intravenous vitamin C therapy alone did not reduce hospital mortality in mechanically ventilated patients with severe sepsis or septic shock.
Entities:
Keywords:
Sepsis; mortality; septic shock; vitamin C
Authors: Avery B Nathens; Margaret J Neff; Gregory J Jurkovich; Patricia Klotz; Katherine Farver; John T Ruzinski; Frank Radella; Iris Garcia; Ronald V Maier Journal: Ann Surg Date: 2002-12 Impact factor: 12.969
Authors: C L Long; K I Maull; R S Krishnan; H L Laws; J W Geiger; L Borghesi; W Franks; T C Lawson; H E Sauberlich Journal: J Surg Res Date: 2003-02 Impact factor: 2.192
Authors: Min Han; Suresh Pendem; Suet Ling Teh; Dinesh K Sukumaran; Feng Wu; John X Wilson Journal: Free Radic Biol Med Date: 2009-10-17 Impact factor: 7.376
Authors: James A Russell; Keith R Walley; Joel Singer; Anthony C Gordon; Paul C Hébert; D James Cooper; Cheryl L Holmes; Sangeeta Mehta; John T Granton; Michelle M Storms; Deborah J Cook; Jeffrey J Presneill; Dieter Ayers Journal: N Engl J Med Date: 2008-02-28 Impact factor: 91.245
Authors: John A Myburgh; Alisa Higgins; Alina Jovanovska; Jeffrey Lipman; Naresh Ramakrishnan; John Santamaria Journal: Intensive Care Med Date: 2008-07-25 Impact factor: 17.440
Authors: Sean S Scholz; Rainer Borgstedt; Nicole Ebeling; Leoni C Menzel; Gerrit Jansen; Sebastian Rehberg Journal: Crit Care Date: 2021-01-06 Impact factor: 9.097
Authors: David C Consoli; Jordan J Jesse; Kelly R Klimo; Adriana A Tienda; Nathan D Putz; Julie A Bastarache; Fiona E Harrison Journal: Nutrients Date: 2020-03-26 Impact factor: 5.717
Authors: Jung-Wan Yoo; Rock Bum Kim; Sunmi Ju; Seung Jun Lee; Yu Ji Cho; Yi Yeong Jeong; Jong Deog Lee; Ho Cheol Kim Journal: Tuberc Respir Dis (Seoul) Date: 2020-06-16
Authors: Eric L Wald; Colleen M Badke; Lauren K Hintz; Michael Spewak; L Nelson Sanchez-Pinto Journal: Pediatr Res Date: 2021-07-31 Impact factor: 3.756